VCU Massey Cancer Center


Massey member directory

For members: update your profile »

« Back to member list

Charles Clevenger, M.D., Ph.D.

Massey Cancer Center research program membership

Cancer Biology

Massey Cancer Center leadership roles

Associate director for precision oncology, VCU Massey Cancer Center

Affiliated leadership roles

Chair, Department of Pathology, VCU

Department affiliations

Professor, Department of Pathology, School of Medicine

Endowed and distinguished chair or professorship

Carolyn Wingate Hyde Chair


MD, Northwestern University (1987)
PhD, Northwestern University (1986)

Awards and honors

Outstanding Faculty Teaching Recognition, 2012, Northwestern University
Pfizer Outstanding Investigator Award, 2003, American Society for Investigative Pathology

Research description

Charles V. Clevenger, MD, PhD is Chair of the Department of Pathology at VCU. His research is focused on prolactin (PRL) receptor signal transduction and function as it pertains to breast cancer and mammary gland development. Within humans, PRL functions at the endocrine and autocrine/paracrine levels as a growth and differentiation factor within the breast, a hypothesis first suggested by his laboratory. Therefore, one of Dr. Clevenger's major aims is the characterization of those mechanisms that regulate PRL and PRL receptor (PRLr) action in normal and neoplastic tissues. PRL function in human tissues is mediated by seven prolactin receptor isoforms, four of which were initially identified and characterized by his lab. These studies utilize both biochemical approaches to examine PRL-PRLr binding and the interaction of the PRLr with its associated transduction pathways that include JAK2/CypA and the Nek3/Vav2/Rac complexes. In addition to these non-genomic transduction pathways, his lab is also examining the direct actions of both PRL and PRLr within the nucleus as transcriptional co-activators in complex with HDAC6/HMGN2/Stat5. As many of these proteins are targets for novel pharmacotherapies, his lab is actively translating these findings through pre-clinical models into Phase I trials. As such, his findings present several opportunities for the development of novel therapies aimed at modulating PRL action during breast tumorigenesis.

Disease focus of research


Research keywords

Animal models,Cancer cell biology,Cell signaling,Metastasis,Molecular medicine,Oncogenes,Precision medicine,Signal transduction

Published research (during tenure as a Massey Cancer Center member)

Search In PubMed

Contact information